In a trial, an anti-inflammatory medication has no benefit for dry age-related macular degeneration.

Published Date: 27 Mar 2024

A phase II clinical trial with individuals with dry age-related macular degeneration (AMD) found that the antibiotic minocycline, which also reduces inflammation, was unable to stop vision loss or the spread of geographic atrophy.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Aspirin Fails to Boost Survival in Colorectal Cancer Trial

2.

Do Anatomy Atlases Reflect Social Inequalities?

3.

A higher risk of chemotherapy-induced peripheral neuropathy is associated with a deficiency in vitamin D prior to treatment.

4.

Some triple negative breast cancers might be avoided by longer breastfeeding

5.

Quizartinib Benefit in AML Limited to FLT3-Mutated Subgroup


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot